Effect of Coronary Slow Flow on Intrinsicoid Deflection of QRS Complex

Table 1

The demographics of the patient and control groups.

	Group
	Control	Patient
Age^1	56.69 ± 6.73	56.35 ± 7.51	0.730
Sex^2
Female	47 (43.12)	52 (47.27)	0.537
Male	62 (56.88)	58 (52.73)
BMI^1	26.6 ± 2.4	26.55 ± 2.87	0.887
Smoking^2
No	78 (71.56)	72 (65.45)	0.331
Yes	31 (28.44)	38 (34.55)
Aspirin^2
No	75 (68.81)	73 (66.36)	0.699
Yes	34 (31.19)	37 (33.64)
RAS blocker^2
No	56 (51.38)	57 (51.82)	0.948
Yes	53 (48.62)	53 (48.18)
Beta blocker^2
No	68 (62.39)	69 (62.73)	0.958
Yes	41 (37.61)	41 (37.27)
Statin^2
No	66 (60.55)	70 (63.64)	0.638
Yes	43 (39.45)	40 (36.36)
KKB^2
No	84 (77.06)	85 (77.27)	0.971
Yes	25 (22.94)	25 (22.73)
Heart rate^1	66.96 ± 6.71	67.35 ± 7.21	0.685
Systolic BP^1	123.17 ± 6.03	124 ± 6.2	0.314
Diastolic BP^1	72.8 ± 5.67	75 ± 6.6	0.009
EF^1	62.44 ± 3.08	61.41 ± 3.28	0.017
LVEDD^1	48.78 ± 2.78	49.61 ± 3.17	0.041
LVESD^1	34.89 ± 2.84	35.5 ± 3.49	0.158
IVSD^1	10.64 ± 0.86	10.62 ± 0.94	0.843
LVPWT^1	9.69 ± 0.6	9.78 ± 0.75	0.308
LA^1	36.03 ± 1.84	36.87 ± 1.52	<0.001
ID V1^1	27.44 ± 4.38	45.85 ± 5.72	<0.001
ID V6^1	38.58 ± 28.89	65.61 ± 5.86	<0.001
PWD^1	20.71 ± 3.94	43.18 ± 7.54	<0.001
TFC LAD^1	16.75 ± 1.16	42.24 ± 8.6	<0.001
TFC Cx^1	15.01 ± 0.8	34.97 ± 5.16	<0.001
TFC RCA^1	14.17 ± 0.81	31.03 ± 2.86	<0.001
TFC^1	15.28 ± 0.61	36.04 ± 5.31	<0.001

¹Independent sample t-test; ²chi-square test.